Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
BeiGene

BeiGene

BeiGene is a small Molecules, Monoclonal Antibodies founded in 2010.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Alex Keown
July 7, 2021
BioSpace
This morning, multiple companies announced clinical and strategic collaborations to develop novel therapies and treatments for various diseases. Here are some of them.
BioSpace
June 28, 2021
BioSpace
Shoreline Biosciences, Inc. today announced the appointment of Mohammad El-Kalay , Ph.D., as Senior VP and Head of CMC
Mark Terry
June 14, 2021
BioSpace
A busy week for clinical trial news as the ASCO meeting wrapped up and the European Hematology Association 2021 Virtual Congress began. Read on for more.
Mark Terry
June 11, 2021
BioSpace
Beigene presented results from three pivotal trials at the 26th EHA2021 Virtual Congress for the effectiveness of their checkpoint inhibitor tislelizumab in relapsed or refractory lymphoma.
BioSpace
June 10, 2021
BioSpace
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the appointment of Jane Huang, M.D. to its Board of Directors.
SHOW MORE

References

Golden logo
By using this site, you agree to our Terms & Conditions.